Enteral Feeding Formulas Market Overview
Enteral nutrition comprises of Tube feeding which is when a special liquid food mixture containing protein, carbohydrates (sugar), fats, vitamins and minerals, is given through the tube into the stomach or small bowel. A growing number of hospitals and ambulatory care services are implementation enteral nutrition as an effective system of clinical nutrition.
Factors such as complications associated with the enteral nutrition, patient safety risks, and the occurrence of feeding and medication errors are expected to restrain the growth of enteral feeding formulas market to a certain extent. The Global enteral feeding formulas market is determined by the rising incidences of the chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for the homecare.
Enteral Feeding Formulas Market Forecast Report (2018-2023)
The Global Enteral Feeding Devices Market worth was USD 4.67 billion in 2018 and estimated to be growing at a CAGR of 7.87%, to reach USD 6.82 billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/enteral-feeding-formulas-devices-market-3331/
Enteral Feeding Formulas Market Segmentation
On the basis of product, the market is segmented into the standard and disease-specific formulas. The standard formulas segment is further divided into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and the other formulas, which primarily include immune-enhancing & wound-healing and formulas for critical care. On the basis of stage, the market is divided into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and the disorders of the heart, renal system, lungs, and liver, along with the psychiatric disorders. The oncology application segment held at the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among the cancer patients. By end user, the market is divided into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies and hospices, nursing homes, and assisted living facilities. On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Key Developments in the Market
March 2017 – Trovita Health Science, an emerging life science company specializing in the medical nutrition, announces U.S. Food and Drug Administration marketing authorization of new SAFE-T FEED device for administering tube feeding formulas.
Some of the prominent players in global enteral feeding formulas market are
- Abbott Laboratories (U.S.)
- Nestlé S.A. (Switzerland)
- Danone S.A. (France)
- Fresenius Kabi AG (Germany)
- Mead Johnson Nutrition Company (U.S.)
- Braun Melsungen AG (Germany)
- Hormel Foods, LLC (U.S.)
- Victus Inc. (U.S.)
- Meiji Holdings Co., Ltd. (Japan)
- Global Health Product Inc. (U.S.).
Market Data Forecast is determined working in the areas of market research, business intelligence and consulting. We have a great experience in research and consulting for various business domains to cater the needs of both individual and corporate clients.